[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note",
    "summary": "In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $470.37, marking a +1.88% move from the previous day.",
    "url": "https://finnhub.io/api/news?id=3324e58708ccc43371d3277d015d648e51a4bceea7a53b69869c581f88cda157",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738623022,
      "headline": "Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note",
      "id": 132631704,
      "image": "https://media.zenfs.com/en/zacks.com/5ecaf2a9bf082a5f3a554e6526b34be0",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $470.37, marking a +1.88% move from the previous day.",
      "url": "https://finnhub.io/api/news?id=3324e58708ccc43371d3277d015d648e51a4bceea7a53b69869c581f88cda157"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors despite daily gains",
    "summary": "Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=be5a585290e3c9d107b524e67ef9c990baa74b46264e4875020f6471898d3282",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738600620,
      "headline": "Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors despite daily gains",
      "id": 132547326,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=be5a585290e3c9d107b524e67ef9c990baa74b46264e4875020f6471898d3282"
    }
  },
  {
    "ts": null,
    "headline": "3 Magnificent Stocks to Buy and Hold Forever",
    "summary": "Here's why they view Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and Vertex Pharmaceuticals (NASDAQ: VRTX) as magnificent stocks to buy and hold forever.  David Jagielski (Eli Lilly): A forever stock you can put in your portfolio and not worry about is Eli Lilly.  The healthcare company's robust financials, solid pipeline of drugs, and growing dividend highlight three of the best reasons to invest in the business.",
    "url": "https://finnhub.io/api/news?id=fd72e612ada35bc5670c8297faeb2e426fa2803f17b74d0d6562e1cd7d6c5647",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738593000,
      "headline": "3 Magnificent Stocks to Buy and Hold Forever",
      "id": 132631705,
      "image": "https://g.foolcdn.com/editorial/images/805884/young-woman-smiling-hands-behind-head.jpg",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Here's why they view Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and Vertex Pharmaceuticals (NASDAQ: VRTX) as magnificent stocks to buy and hold forever.  David Jagielski (Eli Lilly): A forever stock you can put in your portfolio and not worry about is Eli Lilly.  The healthcare company's robust financials, solid pipeline of drugs, and growing dividend highlight three of the best reasons to invest in the business.",
      "url": "https://finnhub.io/api/news?id=fd72e612ada35bc5670c8297faeb2e426fa2803f17b74d0d6562e1cd7d6c5647"
    }
  },
  {
    "ts": null,
    "headline": "Vertex (VRTX) Surges 5.3%: Is This an Indication of Further Gains?",
    "summary": "Vertex (VRTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.",
    "url": "https://finnhub.io/api/news?id=b490aaf08d5e8c33354217a14152cd84cf028aa11c522842d371ab8326a0a9ee",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738591380,
      "headline": "Vertex (VRTX) Surges 5.3%: Is This an Indication of Further Gains?",
      "id": 132631706,
      "image": "https://media.zenfs.com/en/zacks.com/4e067dcfead6ca72f3d024ca0e8efd5c",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex (VRTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.",
      "url": "https://finnhub.io/api/news?id=b490aaf08d5e8c33354217a14152cd84cf028aa11c522842d371ab8326a0a9ee"
    }
  },
  {
    "ts": null,
    "headline": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
    "summary": "Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.",
    "url": "https://finnhub.io/api/news?id=891dd6ded1235f135c4972a30541459064d15d41f3564526823ee0cc04f70aae",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738591212,
      "headline": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
      "id": 132631707,
      "image": "https://media.zenfs.com/en/zacks.com/03fca48475577988aa4e0db94f484b4e",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.",
      "url": "https://finnhub.io/api/news?id=891dd6ded1235f135c4972a30541459064d15d41f3564526823ee0cc04f70aae"
    }
  },
  {
    "ts": null,
    "headline": "Are These 5 Biotech Stocks Set to Beat Q4 Earnings Estimates?",
    "summary": "Let us look at some biotech stocks, AMGN, CRSP, MRNA, SRPT and VRTX, which are poised to beat on fourth-quarter earnings.",
    "url": "https://finnhub.io/api/news?id=3756ee24b5eb170011c6a956f2e8f2d6a862afbbd59715cfc25bc7247edf4f36",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738586580,
      "headline": "Are These 5 Biotech Stocks Set to Beat Q4 Earnings Estimates?",
      "id": 132574537,
      "image": "https://media.zenfs.com/en/zacks.com/9137c6f6ed305652874fd6a3a724cf37",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Let us look at some biotech stocks, AMGN, CRSP, MRNA, SRPT and VRTX, which are poised to beat on fourth-quarter earnings.",
      "url": "https://finnhub.io/api/news?id=3756ee24b5eb170011c6a956f2e8f2d6a862afbbd59715cfc25bc7247edf4f36"
    }
  }
]